Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
7 Reasons Celgene Is the Best Bet in Biotech
Motley Fool
Tue, 10/18/16 - 09:25 am
Celgene
ozanimod
CAR-T
CC-122
CC-220
demcizumab
Mongersen
AVL292
Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook
Yahoo/Benzinga
Sat, 10/8/16 - 03:46 pm
Kite Pharma
clinical trials
KTE-C19
CAR-T
refractory lymphoma
Kite Pharma Claims CAR-T Trial Victory, FDA Filing Next
TheStreet.com
Tue, 09/27/16 - 09:56 am
Kite Pharma
CAR-T
FDA
KTE-C19
diffuse large B-cell lymphoma
Stung by patient deaths, a small Juno study points to a Goldilocks formula for CAR-T
Endpoints
Thu, 09/8/16 - 09:10 am
Juno Therapeutics
CAR-T
JCAR014
Novartis’ CAR-T chief Azam is leaving, but pharma giant denies any ‘retreat’ is underway
Endpoints
Sat, 09/3/16 - 12:06 pm
Novartis
CAR-T
gene therapy
Could Toxicity Issues Topple CAR-T Cancer Therapies?
Motley Fool
Sun, 08/28/16 - 10:09 am
CAR-T
clinical trials
Juno Therapeutics
Kite Pharma
Bluebird Bio
Ziopharma Oncology
Controversial patient deaths in CAR-T study spur a class action suit against Juno
Endpoints
Wed, 08/17/16 - 12:10 pm
Juno Therapeutics
CAR-T
JCAR015
Juno Throws Down The Multiple Myeloma Gauntlet To Bluebird
Seeking Alpha
Tue, 08/9/16 - 10:54 pm
Juno Therapeutics
Multiple Myeloma
Bluebird Bio
CAR-T
Despite trial restart, Juno pushes back launch timeline for CAR-T therapy
BioPharma Dive
Fri, 08/5/16 - 11:23 am
Juno Therapeutics
CAR-T
acute lymphoblastic leukemia
JCAR015
Adaptimmune gets a partial hold on pivotal T-cell study, but it seems OK to breathe now
Endpoints
Thu, 08/4/16 - 09:56 am
Adaptimmune
T-cells
myxoid round cell liposarcoma
CAR-T
cancer immunotherapy
Regeneron leaps into the blockbuster race to develop off-the-shelf immune cell cancer therapies
Endpoints
Tue, 08/2/16 - 09:00 am
Regeneron
drug development
CAR-T
cancer immunotherapy
Adicet Bio
Should Juno Be A Warning To All CAR-T Researchers?
Seeking Alpha
Mon, 08/1/16 - 09:35 am
Juno Therapeutics
CAR-T
Kite grabs a stem cell biology ‘breakthrough’ in race for off-the-shelf T cell therapies
Endpoints
Tue, 07/26/16 - 11:01 am
Kite Pharma
CAR-T
drug development
CAR-T therapies: the future of cancer care, or an industry pipe dream?
Medical Marketing and Media
Mon, 07/25/16 - 10:09 am
CAR-T
cancer
immuno-oncology
Kite Pharma’s CAR-T Clinical Trial To Use Chemotherapy Drug Implicated In Patient Deaths
Xtalks
Fri, 07/15/16 - 10:18 am
Kite Pharma
clinical trials
CAR-T
chemotherapy
Juno Therapeutics
And then there were 4: Juno adds another victim in CAR-T death tally
Endpoints
Thu, 07/14/16 - 09:27 am
Juno Therapeutics
clinical trials
CAR-T
Juno Therapeutics (JUNO) Stock Surges After FDA Lifts Clinical Hold
TheStreet.com
Wed, 07/13/16 - 11:17 am
Juno Therapeutics
FDA
clinical trials
CAR-T
Juno Therapeutics Re-Starts Cancer Trial After Deaths Put Study on Hold
Forbes
Tue, 07/12/16 - 06:53 pm
Juno Therapeutics
FDA
CAR-T
clinical trials
Is Juno's Hold A CAR Crash Or Just A Speed Bump?
Seeking Alpha
Tue, 07/12/16 - 09:28 am
Juno Therapeutics
CAR-T
clinical trials
JCAR015
In Juno patient deaths, echoes seen of earlier failed company
Stat
Sat, 07/9/16 - 09:16 am
Juno Therapeutics
clinical trials
CAR-T
Dendreon
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
next ›
last »